Sensyne Health Share Discussion Threads

[tomboyb] 14/1/2022 16:08

very precarious -

Loan note at 10p conversion -

was tempted but no idea if this will last -

wish u the best but this one is touch and go -

[zen12] 14/1/2022 15:37

Possibly...but MBO offer is now imminent. Hinted in the RNS today.

[rogerc1985] 14/1/2022 15:27

Sub 20 looks likely on Monday

[zen12] 14/1/2022 15:24

That could be the seller out...with that hugh sell?

[the stinger] 14/1/2022 15:18

27-May-21 Peel Hunt Limited Buy - 349.00 Reiteration
24-May-21 Liberum Capital Buy - 310.00 Reiteration
07-May-21 Liberum Capital Buy - 310.00 Reiteration
09-Feb-21 Liberum Capital Buy - 310.00 Reiteration

[mbdx7em21] 14/1/2022 15:17

with the Amati sell printed. happy to buy, business does have very significant potential imo in hands of more competent management. sale at knock down price but enough upside from here imo

[billy3] 14/1/2022 15:14

Yikes. Someone sold 6 million at 20p !!!!

[40 fathoms] 14/1/2022 15:05

Looks like Amati are todays big sellers. Have dumped their whole position. Probably they have a few too many binary outcomes on their books for their liking.

[40 fathoms] 14/1/2022 14:57

Yes. Hard to put the emotion aside but there is a more than decent business here even if it has been very poorly run.

[40 fathoms] 14/1/2022 14:42

One other thing to keep in mind is that JPM are running the process. They don’t take on just any one and the fact they took us on means they would have thought a sale price of well north of GBP 200 million was possible. While todays fun and games will no doubt have affected pricing to a degree it will not have radically altered the future value of the company.

In any event even after the dilution from the warrants we are worth multiples of current share price.

[edwardt] 14/1/2022 14:32

if the mbo happens at these levels i will be spitting feathers.

[zen12] 14/1/2022 14:12

Mr very very good point...the CEO has misled investors. If he thought this was undervalued previously then how on earth he allowed placing at this shocking price...criminal behaviour.

[monster500] 14/1/2022 13:44

Well spotted :)

[terminator101] 14/1/2022 13:41

A lot of sells are showing as sell too. Shocker.

[74tom] 14/1/2022 13:00

Totally agree, it's also shocking that they had the gall to issue 2 x rampy RNS's on Christmas Eve to lure in more innocent PI's. Why not just STFU if you know you're running out of cash?!

[monster500] 14/1/2022 13:00

Allot of buys showing as sells

[mrc2u] 14/1/2022 12:48

Interesting points. Agree with the latter but think the Panel would be hard pressed to object to rescue finance and not even sure what powers they have when there is no offer yetMain point though is how on earth did they not spot until this week that the cash pot was nearly empty? Even without a proper CFO

[40 fathoms] 14/1/2022 12:44

I suspect the Takeover panel would never allow the CEO who is currently discussing an MBO to be involved in the refinancing.

The warrants do open up an interesting (outside) possibility, that we end up with a higher bid than we might otherwise have. With a 20% holding the CEO, has in effect a veto over any bid (you need 75% approval via a scheme of arrangement) so he would obviously favour a bid (possibly lower) that he would approve of. But if his position is reduced to 17% via the dilution from the warrants then it leaves just about enough space to get a bid through that he did not approve of.

[mrc2u] 14/1/2022 12:31

Oh and the CEO, who has oodles of cash, wants to buy the company because he was outraged that it was undervalued at five or six times the current priceBut he is not even putting any more up at 10pWhere are the regulators?

[mrc2u] 14/1/2022 12:28

This looks like a governance shocker. The CEO is obviously out of control. They have been through several chairs and now have one who is in his first job in business. They fired the CFO a while ago and said he wasn't fit for purpose and he rapidly and successfully sued them for wrongful dismissal. They then replaced him with a CFO who is an investor relations guy and not an accountant. Now they tell us they have only £2.8m left.

[billy3] 14/1/2022 12:08

Still tempted to dip my toe in here but it’s still not holding and dropping a little.

Looking at recent trades, some retail investors have woken to a shock and are dumping too as trades are smaller.

If you buy I reckon you’ll make good over time but don’t spend more than you can afford to lose.

Question is for me now (having read press comments) when to buy and how much ?

[ak62] 14/1/2022 12:07

took a gamble, see what happens

[robizm] 14/1/2022 12:04

There were some good points in the RNS such as £29 million potential contracts and buyers interested in purchasing the business. That purchasing price has got a lot better for the potential buyers.

Drug research is a huge business and their database will be bought by someone. I think you can double your money in a short time frame but not without risk which is what investment is.

[rogerc1985] 14/1/2022 11:38

A few Twitter guys are as usual pumping it up. Just because it's 68% down doesn't mean it's the bottom.These swings work when there is an event out of the control of the company which causes a severe drop and not due to fundamentals. Eg like HOC dipped to 85p and rebought and within 1 week was 150pThis however was a bad rns. Lord selling sub 20p could be more.